Molecular Consequences ofBEST1Gene Mutations in Canine Multifocal Retinopathy Predict Functional Implications for Human Bestrophinopathies
- 1 June 2011
- journal article
- research article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 52 (7) , 4497-4505
Abstract
Purpose.: Bestrophin-1 gene (BEST1) mutations are responsible for a broad spectrum of human retinal phenotypes, jointly called bestrophinopathies. Canine multifocal retinopathy (cmr), caused by mutations in the dog gene ortholog, shares numerous phenotypic features with human BEST1-associated disorders. The purpose of this study was the assessment of molecular consequences and pathogenic outcomes of the cmr1 (C73T/R25X) premature termination and the cmr2 (G482A/G161D) missense mutation of the canine model compared with the C87G/Y29X mutation observed in human patients. Methods.: Dogs carrying the BEST1 mutation were introduced into a breeding colony and used to produce either carrier or affected offspring. Eyes were collected immediately after euthanatization at the disease-relevant ages and were harvested for expression studies. In parallel, an in vitro cell culture model system was developed and compared with in vivo results. Results.: The results demonstrate that cmr1 and human C87G-mutated transcripts bypass the nonsense-mediated mRNA decay machinery, suggesting the AUG proximity effect as an underlying transcriptional mechanism. The truncated protein, however, is not detectable in either species. The in vitro model accurately recapitulates transcriptional and translational expression events observed in vivo and, thus, implies loss of bestrophin-1 function in cmr1-dogs and Y29X-affected patients. Immunofluorescence microscopy of cmr2 mutant showed mislocalization of the protein. Conclusions.: Molecular evaluation of cmr mutations in vivo and in vitro constitutes the next step toward elucidating genotype-phenotype interactions concerning human bestrophinopathies and emphasizes the importance of the canine models for studying the complexity of the BEST1 disease mechanism.Keywords
This publication has 46 references indexed in Scilit:
- Gene therapy rescues cone function in congenital achromatopsiaHuman Molecular Genetics, 2010
- Bestrophins and retinopathiesPflügers Archiv - European Journal of Physiology, 2010
- Missense Mutations in a Retinal Pigment Epithelium Protein, Bestrophin-1, Cause Retinitis PigmentosaThe American Journal of Human Genetics, 2009
- Functional properties of murine bestrophin 1 channelBiochemical and Biophysical Research Communications, 2009
- Human Disease-causing Mutations Disrupt an N-C-terminal Interaction and Channel Function of Bestrophin 1Journal of Biological Chemistry, 2009
- Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kineticsProceedings of the National Academy of Sciences, 2008
- Biallelic Mutation of BEST1 Causes a Distinct Retinopathy in HumansThe American Journal of Human Genetics, 2008
- Bestrophin Gene Mutations Cause Canine Multifocal Retinopathy: A Novel Animal Model for Best DiseaseInvestigative Ophthalmology & Visual Science, 2007
- The canonical UPF1-dependent nonsense-mediated mRNA decay is inhibited in transcripts carrying a short open reading frame independent of sequence contextRNA, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001